Comments: NJ A2240 | 2022-2023 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2022-02-07 - Introduced, Referred to Assembly Health Committee [A2240 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A2240 at this time.

Social Comments on NJ A2240

feedback